Ibuprofeno Labesfal (Ibuprofen)

Ibuprofeno Labesfal, an NSAID, acts on the cyclooxygenase pathway to reduce prostaglandin synthesis and relieve symptoms in several common conditions.

• Pain: Provides symptomatic relief of mild to moderate nociceptive pain such as headache, dental pain, musculoskeletal aches, and dysmenorrhea.
• Fever: Lowers elevated body temperature associated with viral or bacterial infections and other febrile states.
• Inflammation: Reduces swelling and discomfort in conditions like arthritis, soft‑tissue injuries, and postoperative inflammation.

• Ibuprofen exerts its therapeutic effect by reversibly inhibiting both cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes. This inhibition decreases the conversion of arachidonic acid to prostaglandins, thereby reducing inflammation, pain signaling, and fever generation at the site of tissue injury or infection.

Adverse reactions may range from mild, transient events to serious, potentially life‑threatening conditions.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia, or mild abdominal pain.
• Headache: transient tension‑type headache.
• Dizziness or vertigo.
• Skin reactions: mild rash or pruritus.
• Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding, which may present as melena or hematemesis.
• Renal impairment, including acute kidney injury, especially in volume‑depleted patients.
• Cardiovascular events such as myocardial infarction or stroke, particularly with high‑dose or prolonged use.
• Severe hypersensitivity reactions, including anaphylaxis or Stevens‑Johnson syndrome.

Before using Ibuprofeno Labesfal, consider the following safety measures.

• Assess renal function: avoid use in patients with severe renal impairment.
• Monitor gastrointestinal risk: use with caution in individuals with a history of ulcers or bleeding.
• Evaluate cardiovascular status: limit use in patients with established heart disease or uncontrolled hypertension.
• Review concomitant medications: avoid concurrent use with other NSAIDs, anticoagulants, or corticosteroids without medical supervision.
• Pregnancy and lactation: discuss potential risks with a healthcare professional before use.
• Store at ambient temperature: keep below 25 °C, retain in the original packaging, and protect from moisture and direct sunlight.

Ibuprofeno Labesfal may alter the efficacy or safety of several co‑administered medicines.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
• Selective COX‑2 inhibitors: additive gastrointestinal toxicity.
• High‑dose aspirin: heightened renal and gastrointestinal adverse effects.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function.
• Diuretics: may enhance nephrotoxic potential.
• Lithium: ibuprofen can raise serum lithium levels, requiring monitoring.